Genomic testing

DIAGNOSTIC_TEST2 trials

Sponsors

Arbeitsgemeinschaft medikamentoese Tumortherapie, Lei Li

Conditions

BRCA1 MutationBRCA2 MutationCancer CervixCancer ColorectalCancer Head NeckCancer LiverCancer RefractoryCancer of Esophagus

Unknown Phase

Genomic Testing and Resulting Medical Decisions

CompletedNCT03301493

Arbeitsgemeinschaft medikamentoese TumortherapieCancer, Bladder, Cancer, Breast, Cancer Cervix +12

Start: 2017-03-30End: 2024-11-30Updated: 2025-04-10

Homologous Recombination Deficiency Status in Epithelial Ovarian Cancer

Lei LiBRCA1 Mutation, BRCA2 Mutation, Chinese +3

Start: 2019-12-07End: 2022-12-07Target: 1300Updated: 2019-12-10